Product Comparison


  Pfizer Pharmaceuticals (Brand) 00009737611 Auromedics Pharmaceuticals 55150033001 Mylan Pharmaceuticals 00378334053 Pfizer Pharmaceuticals (Brand) 00009470913
McKesson # 811706 1233170 885048 721146
Description Depo-Provera® CI Medroxyprogesterone Acetate 150 mg / mL Injection 1 mL Medroxyprogesterone Acetate 150 mg / mL Injection 1 mL Xulane™ Norelgestromin / Ethinyl Estradiol 150 mcg - 35 mcg / 24 Hour Patch 3 Patches depo-subQ provera 104™ Medroxyprogesterone Acetate 104 mg / 0.65 mL Injection 0.65 mL
Manufacturer # 00009737611551500330010037833405300009470913
Brand Depo-Provera® CI Xulane™depo-subQ provera 104™
Manufacturer Pfizer Pharmaceuticals (Brand)Auromedics PharmaceuticalsMylan PharmaceuticalsPfizer Pharmaceuticals (Brand)
Invoice DEPO-PROVERA SAF, SYR 150MG/ML1MLMEDROXYPROGESTERONE ACETATE, PFS 150MG/ML 1MLXULANE NORELGES, PATCH 150-35MG/24HR (3/CT)DEPO-SUBQ PROVERA, SYR 104MG/0.65ML 0.65ML
    Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 26627572054724
Container Type Prefilled SyringePrefilled SyringePouchPrefilled Syringe
Dosage Form InjectionInjectionPatchInjection
Generic Drug Code 11254112541552424471
Generic Drug Name Medroxyprogesterone AcetateMedroxyprogesterone AcetateNorelgestromin / Ethinyl EstradiolMedroxyprogesterone Acetate
NDC Number 00009737611551500330010037833405300009470913
Quantity 3 Patches
Strength 150 mg / mL150 mg / mL150 mcg - 35 mcg / 24 Hour104 mg / 0.65 mL
Type IntramuscularIntramuscularTransdermalSubcutaneous
UNSPSC Code 51351612513515095135241451351612
Volume 1 mL1 mL0.65 mL
Application Contraceptive AgentContraceptive AgentContraceptive AgentContraceptive Agent
Country of Origin UnknownUnknownUnknownUnknown
Product Dating McKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 days
Features and Benefits
  • Depo-Provera CI is a progestin indicated only for the prevention of pregnancy
  • The recommended dose is 150 mg of Depo-Provera CI every 3 months (13 weeks) administered by deep, intramuscular (IM) injection in the gluteal or deltoid muscle
  • Prefilled syringes packaged with 22-gauge x 1-1/2 inch Terumo® SurGuard™ needles
  • Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP]
  • depo-subQ provera 104 must be given by subcutaneous injection into the anterior thigh or abdomen, once every 3 months (12 to 14 weeks)
  • depo-subQ provera 104 is not formulated for intramuscular injection
  • The pre-filled syringe of depo-subQ provera 104 must be vigorously shaken just before use to create a uniform suspension
  • Supplied as a pre-filled syringe, packaged with a 26-gauge x 3/8 inch Terumo® Surguard™ needle
  • Store at controlled room temperature 20º to 25º C (68º to 77ºF)